Thermo Fisher Scientific Inc., the world leader in serving science, has officially opened its U.S. Precision Medicine Science centre (PMSC) in Cambridge, Mass. The centre offers access to advanced "omics" technologies and expertise to help collaborators develop analytical workflows that generate precise molecular profiles of patients. This information will ultimately be used in clinical settings to more effectively treat disease.

In addition to providing access to the industry's most advanced analytical technologies, the PMSC's team of in-house scientists helps partners develop standard protocols that enable them to compress R&D timelines and quickly progress from biomarker discovery to assay development. The team includes Thermo Fisher experts in biochemistry, mass spectrometry, molecular biology and data science.

The PMSC offers access to advanced technologies spanning genomic, proteomic and metabolomic analysis. From analyzing genomic data with next-generation sequencers to identifying proteins and metabolites using advanced mass spectrometry, collaborators can rapidly move from research to clinical workflow development.